Cylex, Inc.

Website Links

Description

is a life science company that manufactures and develops patented in vitro diagnostic products for the assessment of immunity. These products have utility for physicians treating life-threatening diseases or conditions who seek to optimize therapy through individualized management of a patient’s immune system, thereby reducing side effects, improving clinical response and quality of life. ImmuKnow™ - the CylexImmune Cell Function Assay is intended to be used as an adjunct to post-transplantation drug level monitoring along with other clinical indicators. Cylex’s patented platform technology will also provide an innovative approach for measuring immune activity in AIDS and cancer patients, and those with infectious diseases, autoimmune or other immune system disorders.An SBIR contract with the Department of Defense involved developing methods for monitoring immune response to a vaccine for Q-fever. From this preliminary work, the Company's method patent for the measurement of T cell activation arose. The growing company portfolio has patents in the U.S. and Australia and pending patents in Europe, Canada, and Japan.

Companies nearby